Codes / ICD10CM / E70.33

E70.33 Albinism with hematologic abnormality

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Albinism with hematologic abnormality (ICD-10-CM Code: E70.33)

Summary

Albinism with hematologic abnormality is a genetic condition characterized by reduced or absent melanin production, affecting pigmentation of the skin, hair, and eyes, alongside associated hematologic abnormalities. This condition may lead to vision problems due to abnormal development of the optic nerves and retinas, and hematologic findings may include anemia, leukopenia, or thrombocytopenia.

Causes

Albinism with hematologic abnormality results from genetic mutations that disrupt melanin synthesis or transport, often involving genes critical for both pigmentation and hematopoiesis. These mutations impair melanin production, a pigment essential for normal pigmentation and eye development, and may also affect blood cell formation.

Risk Factors

  • Genetic inheritance; typically autosomal recessive, requiring mutations in both copies of a gene.
  • Family history of albinism with hematologic abnormalities.
  • Higher carrier rates in certain populations for specific genetic variants.

Symptoms

  • Pale skin, light hair, and light-colored eyes.
  • Vision issues, including nystagmus, strabismus, photophobia, and reduced visual acuity.
  • Hematologic abnormalities, such as anemia, leukopenia, or thrombocytopenia.
  • Increased susceptibility to sunburn and skin damage due to lack of melanin.

Diagnosis

Diagnosis involves a physical exam to assess pigmentation, ocular evaluations by an ophthalmologist, hematologic testing to identify blood abnormalities, and genetic testing to confirm mutations. Clinical evaluation is often necessary, as newborn screening may not detect this condition.

Treatment Options

Management focuses on symptom relief: corrective lenses for vision problems, protective eyewear, and sun protection for skin. Hematologic abnormalities may require monitoring or specific interventions based on severity.

Prognosis and Follow-Up

Prognosis depends on the severity of hematologic and ocular involvement. Regular follow-up with ophthalmologists and hematologists is recommended to monitor vision and blood cell counts, and to address complications promptly.

Complications

  • Severe vision impairment or blindness.
  • Increased risk of skin cancer due to sun sensitivity.
  • Complications from hematologic abnormalities, such as bleeding or infection.
  • Social or psychological challenges related to appearance or vision loss.

Lifestyle & Prevention

  • Use sunscreen and protective clothing to reduce sunburn risk.
  • Regular eye exams to manage vision issues.
  • Avoid activities with high sun exposure or injury risk.
  • Genetic counseling for families with a history of the condition.

When to Seek Professional Help

Seek medical attention if experiencing sudden vision changes, severe sunburn, unexplained fatigue, or signs of bleeding or infection. Prompt evaluation is important for managing complications.

Tips for Medical Coders

Document the presence of hematologic abnormalities (e.g., anemia, leukopenia) to support the E70.33 code. Ensure clinical notes specify both pigmentation and hematologic findings, as this code requires documentation of both components.

Book a walkthrough

E70.33 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.